IL22 and bacterial infectious disease: Therefore, we first examined the mRNA expression levels of AsT-bet, IFNγ, IL-22, and natural killer enhancement factor (NKEF)-A at different time intervals following bacterial infection in the lymphoid and mucosal tissues of the co-habitants, i.e., spleen, head kidney, skin, and intestine, respectively.